Cargando…
Discovery of Hordenine as a Potential Inhibitor of Pyruvate Dehydrogenase Kinase 3: Implication in Lung Cancer Therapy
Design and development of potential pyruvate dehydrogenase kinase 3 (PDK3) inhibitors have gained attention because of their possible therapeutic uses in lung cancer therapy. In the present study, the binding affinity of naturally occurring alkaloids, hordenine, vincamine, tryptamine, cinchonine, an...
Autores principales: | Anwar, Saleha, Mohammad, Taj, Shamsi, Anas, Queen, Aarfa, Parveen, Shahnaz, Luqman, Suaib, Hasan, Gulam Mustafa, Alamry, Khalid A., Azum, Naved, Asiri, Abdullah M., Hassan, Md. Imtaiyaz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7277448/ https://www.ncbi.nlm.nih.gov/pubmed/32422877 http://dx.doi.org/10.3390/biomedicines8050119 |
Ejemplares similares
-
Discovery of Harmaline as a Potent Inhibitor of Sphingosine
Kinase-1: A Chemopreventive Role in Lung Cancer
por: Roy, Sonam, et al.
Publicado: (2020) -
Rosmarinic Acid Exhibits Anticancer Effects via MARK4 Inhibition
por: Anwar, Saleha, et al.
Publicado: (2020) -
Elucidation of Dietary Polyphenolics as Potential Inhibitor of Microtubule Affinity Regulating Kinase 4: In silico and In vitro Studies
por: Khan, Parvez, et al.
Publicado: (2017) -
MARK4 Inhibited by AChE Inhibitors, Donepezil and Rivastigmine Tartrate: Insights into Alzheimer’s Disease Therapy
por: Shamsi, Anas, et al.
Publicado: (2020) -
Inhibiting Cyclin-Dependent
Kinase 6 by Taurine: Implications
in Anticancer Therapeutics
por: Yousuf, Mohd, et al.
Publicado: (2022)